Michael F Mahoney insider trades

Open-market stock purchases and sales by Michael F Mahoney, Chairman, President & CEO at Boston Scientific Corp, from SEC Form 4 filings since Nov 1, 2011.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +141%.

Recent trades

DateStockTradeValue
May 28, 2026BSX Boston Scientific CorpSold (not open market)—
May 14, 2026CVS CVS HEALTH CorpBought (not open market)$169K
Feb 16, 2026BSX Boston Scientific CorpSold (not open market)$588K
Feb 16, 2026BSX Boston Scientific CorpBought (not open market)—
Feb 14, 2026BSX Boston Scientific CorpSold (not open market)$597K
Feb 14, 2026BSX Boston Scientific CorpBought (not open market)—
Feb 13, 2026BSX Boston Scientific CorpBought (not open market)—
Feb 13, 2026BSX Boston Scientific CorpSold (not open market)$9.9M
Feb 13, 2026BSX Boston Scientific CorpBought (not open market)—
Feb 12, 2026BSX Boston Scientific CorpSold (not open market)$491K
Feb 12, 2026BSX Boston Scientific CorpBought (not open market)—
Feb 12, 2026BSX Boston Scientific CorpBought (not open market)—
Feb 12, 2026BSX Boston Scientific CorpBought (not open market)—
Feb 2, 2026BSX Boston Scientific CorpSold$113K
Feb 2, 2026BSX Boston Scientific CorpSold$14.9M
Feb 2, 2026BSX Boston Scientific CorpBought (not open market)—
Feb 2, 2026BSX Boston Scientific CorpBought (not open market)—
Nov 20, 2025CVS CVS HEALTH CorpBought (not open market)$154K
Oct 30, 2025BSX Boston Scientific CorpSold (not open market)—
Oct 29, 2025BSX Boston Scientific CorpBought (not open market)—
Oct 29, 2025BSX Boston Scientific CorpBought (not open market)—

Companies traded

  • BSX Boston Scientific Corp: 2 buys, 35 sales, last May 28, 2026
  • CVS CVS HEALTH Corp: 2 buys, last May 14, 2026
  • BAX Baxter International Inc: other filings, last May 2, 2023

Get free alerts when Michael F Mahoney files a new trade →